Mephentermine
| Mephentermine | |
|---|---|
| Salts [] | |
|---|---|
| Mephentermine hemisulfate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 163.26 g/mol [1] |
| Appearance | LIQUID [1] |
| Odor | FISHY AMINE ODOR [1] |
| Melting point | < 25 °C [1] |
| Solubility | 1 G DISSOLVES IN 20 ML WATER, ABOUT 150 ML ETHANOL (95%); PRACTICALLY INSOL IN CHLOROFORM /SULFATE DIHYDRATE/ [1] |
| Predicted LogP | 2.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H17N |
| IUPAC name | N,2-dimethyl-1-phenylpropan-2-amine |
| SMILES | CC(C)(CC1=CC=CC=C1)NC |
| InChI | InChI=1S/C11H17N/c1-11(2,12-3)9-10-7-5-4-6-8-10/h4-8,12H,9H2,1-3H3 |
| InChIKey | RXQCGGRTAILOIN-UHFFFAOYSA-N |
| CAS number | 100-92-5 |
| UNII | TEZ91L71V4 |
| PubChem CID | 3677 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Intravenous, intramuscular, oral, inhalation |
Mephentermine (also known as Mephenterdrine, Mephenterdrinum, Mefenterdrin, Mefentermin, Mephetedrine, Mephine, Vialin, N-Methylphentermine, Wyfentermina or Wyamine) is a substance of the phentermine class.
Chemistry
Salts []
Mephentermine is typically found in the form of its hemisulfate salt.
Stereochemistry []
Mephentermine is achiral.
Druglikeness
Lipinski's rule of five
Mephentermine matches Lipinski's rule of five.Pharmacology
ATC Classification
- cardiovascular system (C)
- cardiac therapy (C01)
- cardiac stimulants excl. cardiac glycosides (C01C)
- adrenergic and dopaminergic agents (C01CA)
- mephentermine (C01CA11)
MeSH Classification
- sympathomimetics (M0020947)
- vasoconstrictor agents (M0022551)
- adrenergic alpha-1 receptor agonists (M0543920)
Mechanism of action []
Mephentermine is an alpha adrenergic receptor agonist, but also acts indirectly by releasing endogenous norepinephrine. Cardiac output and systolic and diastolic pressures are usually increased. A change in heart rate is variable, depending on the degree of vagal tone. Sometimes the net vascular effect may be vasodilation. Large doses may depress the myocardium or produce central nervous system (CNS) effects. [1]
Experience reports
Legal status []
- United States: Mephentermine is a Schedule I under the "Controlled Substances Act".
See also []
External links []
- Mephentermine (Wikipedia)
- Mephentermine (PubChem)
- Mephentermine (Wikidata)
- Mephentermine (DrugBank)
- Mephentermine (ChEMBL)
- Mephentermine (ChEBI)
- Mephentermine (Common Chemistry)
- Mephentermine (HMDB)
- Mephentermine (KEGG)
- Mephentermine (EPA DSSTox)
- Mephentermine (Effect Index)
- Mephentermine (UNII)
- Mephentermine (Erowid)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3677, Mephentermine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3677
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Mephentermine. UNII: TEZ91L71V4. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/TEZ91L71V4
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 12:01:28 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 12:01:24 |
| erowid | ok | 2026-11-20 12:01:28 |
| gsrs | ok | 2026-11-20 12:01:25 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015452) | 2026-11-20 12:01:24 |
| kegg | ok | 2026-11-20 12:01:26 |
| pubchem | ok | 2026-11-20 12:01:24 |
| missing (no r/tripreports posts mention it) | 2026-11-20 12:01:24 | |
| sider | missing (not in SIDER) | 2026-11-20 12:01:24 |
| structure | ok | 2026-11-20 12:01:24 |
| wikipedia | ok | 2026-11-20 12:01:24 |